Pheochromocytomas: Imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET

Radiology

Volumn 212, Issue 1, 1999, Pages 35-41

  Shulkin, Barry L ^a   Thompson, Norman W ^b   Shapiro, Brahm ^a   Francis, Isaac R ^b   Sisson, James C ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Adrenal gland, emission CT (ECT); Fluorine, radioactive metaiodobenzylguanidine (MIBG); Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE; FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADRENAL GLAND; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HYPERTENSION; MALE; METASTASIS; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTIGRAPHY; TUMOR LOCALIZATION;

EID: 0032967372     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.212.1.r99jl3035     Document Type: Article

References (31)

1. Bravo EL. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 1994; 15:356-368.
2. Gifford RW Jr, Manger WM, Bravo EL. Pheochromocytoma. Endocrinol Metab Clin North Am 1994; 23:387-404.
3. Werbel SS, Ober KP. Pheochromocytoma: update on diagnosis, localization, and management. Med Clin North Am 1995; 79:131-153.
4. Ram CV, Fierro-Carrion GA. Pheochromocytoma. Semin Nephrol 1995; 15:126-137.
5. Stewart BH, Bravo EL, Haaga J, Meaney TF, Tarazi R. Localization of pheochromocytoma by computed tomography. N Engl J Med 1978; 299:460-461.
6. 131I-MIBG scintigraphy in diagnosing pheochromocytoma. AJR 1983; 141:719-725.
7. Connor CS, Hermreck AS, Thomas JH. Pitfalls in the diagnosis of pheochromocytoma. Am Surg 1988; 54:634-636.
8. Quint LE, Glazer GM, Francis IR, Shapiro B, Chenevert TL. Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 scintigraphy. Radiology 1987; 165:89-93.
9. Velchik MG, Alavi A, Kressel HY, Engelman K. Localization of pheochromocytoma: MIBG, CT, and MRI correlation. J Nucl Med 1989; 30:328-336.
10. Chatal JF, Charbonnel B. Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma. J Clin Endocrinol Metab 1985; 61:769-772.
11. 123I-metaiodobenzylguanidine and x-ray computed tomography: a comparative study. Clin Radiol 1988; 39:502-506.
12. Samaan NA, Mickey RC. Pheochromocytoma. Semin Oncol 1987; 14:297-305.
13. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH. Iodine-131 meta-iodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 1985; 26:576-585.
14. Solanki KK, Bomanji J, Moyes J, et al. A pharmacological guide to medicines which interfere with biodistribution of radiolabelled metaiodobenzylguanidine (MIBG). Nucl Med Comm 1992; 13:513-521.
15. Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thompson NW. PET FDG localization of pheochromocytomas which fail to accumulate MIBG. Radiology 1993; 186:711-715.
16. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluro-2-D-deoxyglucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27:235-238.
17. Shulkin BL, Hutchinson RJ, Castle VP, Yanik GA, Shapiro B, Sisson JC. Neuroblastoma: positron emission tomography with 2-[fluorine-18]fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology 1996; 199:743-750.
18. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH. Iodine-131 meta-iodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 1985; 26:576-585.
19. Lynn MD, Shapiro B, Sisson JC, et al. Pheochromocytomas and the normal adrenal medulla: improved visualization with I-123-MIBG scintigraphy. Radiology 1985; 156:789-792.
20. Keyes JW Jr. SUV: standard uptake or silly useless value (editorial). J Nucl Med 1995; 36:1836-1839.
21. Brown RS, Wahl RL. Overexpression of glut-1 glucose transporter in human breast cancer. Cancer 1993; 72:2979-2785.
22. Paul R, Johansson R, Kellokumpu-Lehtinen PL, Soderstrom KO, Kangas L. Tumor localization with 18F-2-fluoro-2-deoxy-D-glucose: comparative autoradiography, glucose 6-phosphatase histochemistry, and histology of renally implanted sarcoma of the rat. Res Exp Med (Berl) 1985; 185:87-95.
23. Graham MM, Spence AM, Muzi M, Abbott GL. Deoxyglucose kinetics in rat brain tumor. J Cereb Blood Flow Metab 1989; 9:315-322.
24. Shulkin BL, Shapiro B. Current concepts on the diagnostic use of MIBG in children. J Nucl Med 1998; 39:679-688.
25. Gelfand MJ. I-123-MIBG and I-131-MIBG imaging in children with neuroblastoma (abstr). J Nucl Med 1996; 37 (suppl):35P.
26. 131I-MIBG scintigraphy. Clin Nucl Med 1986; 11:851-854.
27. Tenenbaum R, Lumbroso J, Schlumberger M, et al. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med 1995; 36:1-6.
28. Shulkin BL, Wieland DM, Schwaiger M, et al. PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med 1992; 33:1125-1131.
29. Shulkin BL, Wieland DM, Shapiro B, Sisson JC. PET epinephrine studies of pheochromocytoma (abstr). J Nucl Med 1995; 36(suppl): 22P-23P.
30. Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35:1771-1776.
31. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992; 184:441-444.